Weight regain following GLP-1RA discontinuation is common and often rapid, indicating that pharmacological appetite suppression does not permanently reset biological weight-defense systems ( Postbiotics introduce a contrasting paradigm
The subcutaneous injections available in the United States are dulaglutide (Trulicity, Eli Lilly, for type 2 diabetes), liraglutide (Victoza, Novo Nordisk, for type 2 diabetes), semaglutide (Ozempic, Novo Nordisk, for type 2 diabetes and Wegovy, for weight loss), tirzepatide (Mounjaro, Eli Lilly, for type 2 diabetes), and Zepbound (Eli Lilly, for weight loss)
Cost considerations Compounded tirzepatide with levocarnitine typically costs more than plain compounded tirzepatide
Both temperature extremes result in a medication that looks normal to the naked eye but contains a lower concentration of functional semaglutide